EPHA2 and breast cancer: Of note, fluorescently tagged streptavidin-conjugated biotinylated agents targeted TNBC cells in orthotopic mouse models as well, thus highlighting the potential use of these agents to selectively deliver chemotherapy to EPHA2-overexpressing BC [42].